H1B Salary Data

Home › Employers › The Lowy Medical Research Institute

The Lowy Medical Research Institute: H-1B salaries and sponsorship

The Lowy Medical Research Institute filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $120,000.

Applications (LCAs)3
Certified3
Employer addressLa Jolla, CA
H-1B dependent employerNo
Median offered salary$120,000
Middle half of salaries$100,000–$185,000
10th–90th percentile$88,000–$224,000

Does The Lowy Medical Research Institute sponsor H-1B visas?

The Lowy Medical Research Institute filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 3, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Chief Medical Officer1$250,000
Mass Spectrometry Analyst1$80,000
Staff Scientist1$120,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20243$120,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Staff Scientist$120,000–$189,750
Level II
La Jolla, CASep 3, 2024Feb 1, 2025Certified
Mass Spectrometry Analyst$80,000
Level II
La Jolla, CAMay 31, 2024Jul 1, 2024Certified
Chief Medical Officer$250,000
Level II
La Jolla, CAMar 13, 2024May 6, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).